Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jan 13, 2017
Targets & Mechanisms
Gut control
...diagnostics and therapeutics for obese patients with and without Type II diabetes Preclinical October 2014
MetaboGen AB
...
Read More
BioCentury
|
Dec 2, 2016
Financial News
MetaboGen completes venture financing
...raised by
MetaboGen
from the investor to SEK12 million ($1.4 million).
MetaboGen AB
, Gothenburg, Sweden Alex Himes
MetaboGen AB
...
Read More
Items per page:
10
1 - 2 of 2
BioCentury
|
Jan 13, 2017
Targets & Mechanisms
Gut control
...diagnostics and therapeutics for obese patients with and without Type II diabetes Preclinical October 2014
MetaboGen AB
...
Read More
BioCentury
|
Dec 2, 2016
Financial News
MetaboGen completes venture financing
...raised by
MetaboGen
from the investor to SEK12 million ($1.4 million).
MetaboGen AB
, Gothenburg, Sweden Alex Himes
MetaboGen AB
...
Read More
Items per page:
10
1 - 2 of 2
Previous page
Next page